Clinical Trials Directory

Trials / Completed

CompletedNCT06018298

Evaluation of Excellence in Italy's Residence for Execution of Security Measure

Evaluation of Excellence in Italy's Residences for Execution of Security Measures

Status
Completed
Phase
Study type
Observational
Enrollment
245 (actual)
Sponsor
University of Bari · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The model of care for forensic psychiatry in Italy was changed by law (Law 81/2014) so that the six legacy secure forensic hospitals (Judicial Psychiatric Hospitals, OPG) were closed and new secure community residences for the execution of security measures (REMS) were opened in each of the 20 regions of Italy. This transition was in place by 2015. This observational study evaluates the health gains for patients both previously in OPGs and those admitted first to REMS. Health gains assessed include recovery measured by symptoms, function, need for therapeutic security and recovery of legal autonomy.

Detailed description

All those detained in REMS in the twelve month period 2019 to 2020 form the reference population. Samples are assessed for symptom severity (BPRS), global function (GAF), cognitive function (MMSE), risk and protective factors for violence (HCR-20, SAPROF), personality factors (PCL-R), measures of need for therapeutic security (DUNDRUM-1), treatment response relevant to violence and mental illness (DUNDRUM-3) and forensic recovery (DUNDRUM-4). Outcome measures include violent and challenging behaviour (MOAS), length of stay, conditional (legal) discharge.

Conditions

Interventions

TypeNameDescription
OTHERTreatment as usual (TAU)the components of treatment as usual (TAU) are summarised and assessed by the items of the DUNDRUM-3: physical health, mental health, substance misuse, problem behaviours, self care and activities of daily living, education occupation and creativity, family and intimacy.

Timeline

Start date
2018-07-01
Primary completion
2022-12-03
Completion
2022-12-03
First posted
2023-08-30
Last updated
2023-09-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06018298. Inclusion in this directory is not an endorsement.